1h Free Analyst Time
The gene panel market is forecasted to grow by USD 5403.9 million during 2023-2028, accelerating at a CAGR of 23.44% during the forecast period. The report on the gene panel market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing use of gene panels in cancer-targeted therapies, increasing number of people with genetic disorders, and decreasing cost of next generation sequencing (NGS) gene panel tests.
The gene panel market is segmented as below:
By Product
- Small panel testing
- Large panel testing
By Technique
- Amplicon
- Hybridization
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the gene panel market covers the following areas:
- Gene panel market sizing
- Gene panel market forecast
- Gene panel market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Technique
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global gene panel market: Agilent Technologies Inc., Azenta Inc., BGI Genomics Co. Ltd., CENTOGENE NV, Color Health Inc., Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Fagron NV, GenXPro GmbH, Illumina Inc., Invitae Corp., MedGenome Labs Ltd., MGZ Medizinisch Genetisches Zentrum, Novogene Co. Ltd., OPKO Health Inc., Oxford Nanopore Technologies plc, QIAGEN NV, Quest Diagnostics Inc., and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is collaboration to maximize research efficiency."
According to the report, one of the major drivers for this market is the growing use of gene panels in cancer-targeted therapies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agilent Technologies Inc.
- Azenta Inc.
- BGI Genomics Co. Ltd.
- CENTOGENE NV
- Color Health Inc.
- Danaher Corp.
- Eurofins Scientific SE
- F. Hoffmann La Roche Ltd.
- Fagron NV
- GenXPro GmbH
- Illumina Inc.
- Invitae Corp.
- MedGenome Labs Ltd.
- MGZ Medizinisch Genetisches Zentrum
- Novogene Co. Ltd.
- OPKO Health Inc.
- Oxford Nanopore Technologies plc
- QIAGEN NV
- Quest Diagnostics Inc.
- Thermo Fisher Scientific Inc.
